|
Volumn 110, Issue 8, 2014, Pages 2021-2029
|
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
N ACETYLGALACTOSAMINYLTRANSFERASE;
POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE;
POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;
TUMOR MARKER;
AGED;
ARTICLE;
CANCER STAGING;
DISEASE FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
GLYCOSYLATION;
HUMAN;
KAPLAN MEIER METHOD;
MALE;
MIDDLE AGED;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PROGNOSIS;
STOMACH TUMOR;
AGED;
DISEASE-FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GLYCOSYLATION;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
MOLECULAR TARGETED THERAPY;
N-ACETYLGALACTOSAMINYLTRANSFERASES;
NEOPLASM STAGING;
PROGNOSIS;
STOMACH NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84901827505
PISSN: None
EISSN: 15321827
Source Type: Journal
DOI: 10.1038/bjc.2014.93 Document Type: Article |
Times cited : (21)
|
References (0)
|